Delivery Order SPE2DB20D3505-SPE2DB25FU7E7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $2,751.58, was awarded on September 8, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count packages). The contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (100-count) with a contract value of $2,035.44. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award involves no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FU7E7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ramelteon 8 mg tablets (30-count units) with a ceiling value of $2,269.62. This firm fixed price contract, with an ultimate completion date of June 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement standards. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a $999,999,999.00 prime IDC with the DLA through December 2026 that serves as the foundational vehicle for this delivery order. The company supplies a comprehensive range of pharmaceutical products and medical commodities to support military and federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Ramelteon, a medication used in treating sleep disorders, exemplifies the company's role in providing essential pharmaceutical products across diverse therapeutic domains to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/30/25 |